CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Dr. Reddy's Laboratories launches Sodium Nitroprusside Injection

DSIJ Intelligence 0 705 Article rating: No rating

Dr. Reddy’s Laboratories announced the launching of Sodium Nitroprusside injection, 50 mg/2 mL (25 mg/mL) single-dose Vial in the U.S. Market. It is the therapeutic generic equivalent of Nitropress (sodium nitroprusside) Injection, 50 mg/2ml vial, belonging to Hospira, Inc. and was launched post the USFDA approvals.

Shriram Transport: Rating agencies revise outlook

DSIJ Intelligence 0 2282 Article rating: 3.3

Rating agencies, Fitch Ratings and S&P Global Ratings, revised Shriram Transport Finance Company Limited's (STFC) credit rating. Fitch Ratings affirmed STFC’s long-term issuer default rating (IDR) at 'BB+’ with 'stable outlook' and S&P Global Ratings has affirmed 'BB+/B' issuer credit ratings on the company and 'BB+' long-term issue rating on its senior secured notes, also revising the outlook to 'negative' from 'stable' on the basis of weaker economic condition

Dish TV India zooms by nearly 14 per cent

DSIJ Intelligence 0 2548 Article rating: 5.0

Dish TV had recently made an announcement about CARE Ratings, downgrading the company’s short-term bank facilities rating to ‘CARE D’ from ‘CARE A4+’. After the company mentioned that the default in debt repayment was due to temporary cash shortfall, which is because of peak payment commitments to suppliers, the stock jumped by 13.85 per cent.

BASF to double capacity for polymer dispersions

DSIJ Intelligence 0 1838 Article rating: 5.0

BASF intimated the exchanges about its intent to double the production capacity for polymer dispersions with a new production line at its site, located in Dahej in India. The company aims to provide a reliable supply of high-quality dispersion solutions to customers in the current fast-growing Indian and South Asian markets through this investment.

Lupin launches connected Smart Device-Adhero in India

DSIJ Intelligence 0 3111 Article rating: 3.0

Lupin has launched 'Adhero', which is the first-of-its-kind, connected smart device in India to track usage pattern of metered dose inhaler (MDI) by patients. The pharma major also announced the rollout of Hydrocortisone Valerate Cream USP, 0.2%, which is for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients.

Dr. Reddy's Laboratories announces the launch of Doxercalciferol Injection

DSIJ Intelligence 0 2233 Article rating: 3.5

Dr. Reddy's has launched Doxercalciferol Injection, 4 mcg/2 ml (2 mcg/ml) multiple-dose vials, a therapeutic generic equivalent of Hectorol (doxercalciferol) Injection 4 mcg/2 ml (2 mcg/ml) multiple-dose vials, which has been approved by the U.S. Food and Drug Administration (USFDA).

Market wrap

DSIJ Intelligence 0 748 Article rating: 2.7

The Sensex and the Nifty closed today's session at 40345.08 and 11912.95 levels, closing flat or adding 0.05% each, over their previous closing.

MRF to raise funds

DSIJ Intelligence 0 3987 Article rating: 4.3

The Board Directors of MRF Limited approved to raise funds by issuing Non-convertible Debentures on private placement basis, aggregating to approximately Rs. 102 crores in one or more tranches.

Inox Wind gains on order

DSIJ Intelligence 0 2840 Article rating: 3.7

Inox Wind has received an order from ReNew Power Ltd under the SECI - 2 regime for 38MW wind power project to be developed at Anjar in Gujarat. Reacting to this news, the stock of the company gained by 4.19 per cent in today's morning trading session.

Cadila clears USFDA inspection

DSIJ Intelligence 0 1181 Article rating: 5.0

Cadila Healthcare’s manufacturing facility located in Baddi, has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA), stating that the classification of the facility is in ‘No Action Indicated (NAI)'. The USFDA had conducted inspection at the company’s formulations manufacturing facility at Baddi in Himachal Pradesh from July 15-19, 2019.

ONGC reports of oil discoveries at exploration blocks located in Colombia and Brazil

DSIJ Intelligence 0 3845 Article rating: 3.5

ONGC Videsh which is wholly owned subsidiary of Oil and Natural Gas Corporation Limited (ONGC) has reported of oil discoveries in its onshore exploration block CPO-5 in Colombia located in the Llanos basin and major gas in the deep offshore exploration block BM-SEAL4  in Brazil located in the Sergipe Alagoas Basin.

Sun Pharma launched Drizalma Sprinkle for treatment of various disorders

DSIJ Intelligence 0 2671 Article rating: 5.0

A subsidiary of Sun Pharma launched Drizalma Sprinkle in the United States. It is the first and only USFDA approved sprinkle formulation of Drizalma Sprinkle which is delayed-release duloxetine capsules used in treatment of patients suffering from neuro-psychiatric and/or pain disorder accompanied with difficulty swallowing.

RSS
123456789

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR